Trials / Completed
CompletedNCT00987727
Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and efficacy of OPTIVE® MD for ocular surface integrity in symptomatic dry eye condition in absence of obvious eye-lid inflammation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD) | One drop in each eye three to six times daily, as needed |
| DRUG | sodium hyaluronate 0.18% (VISMED® Multi) | One drop in each eye three to six times daily, as needed |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2010-07-01
- Completion
- 2010-09-01
- First posted
- 2009-10-01
- Last updated
- 2011-09-21
- Results posted
- 2011-09-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00987727. Inclusion in this directory is not an endorsement.